|
C3ORF21 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.757190E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.298000E-01 |
| Normal-vs-Stage2 |
9.832600E-01 |
| Normal-vs-Stage3 |
7.637700E-02 |
| Normal-vs-Stage4 |
5.355200E-01 |
| Stage1-vs-Stage2 |
2.001000E-01 |
| Stage1-vs-Stage3 |
2.453200E-01 |
| Stage1-vs-Stage4 |
5.274600E-01 |
| Stage2-vs-Stage3 |
9.552400E-02 |
| Stage2-vs-Stage4 |
5.370000E-01 |
| Stage3-vs-Stage4 |
1.472990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.938250E-01 |
| Normal-vs-AfricanAmerican |
1.511950E-01 |
| Normal-vs-Asian |
5.750200E-01 |
| Caucasian-vs-AfricanAmerican |
4.055200E-01 |
| Caucasian-vs-Asian |
8.672600E-01 |
| AfricanAmerican-vs-Asian |
8.873800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.105000E-01 |
| Normal-vs-Female |
1.941380E-01 |
| Male-vs-Female |
9.221000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.014000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.703410E-01 |
| Normal-vs-Age(61-80Yrs) |
4.517800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.617600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.334000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.951520E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.745570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.849200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.123200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.332800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.530630E-01 |
| Normal-vs-Grade 2 |
1.689810E-01 |
| Normal-vs-Grade 3 |
2.803200E-01 |
| Normal-vs-Grade 4 |
1.946990E-01 |
| Grade 1-vs-Grade 2 |
2.899800E-01 |
| Grade 1-vs-Grade 3 |
3.361600E-01 |
| Grade 1-vs-Grade 4 |
3.934600E-01 |
| Grade 2-vs-Grade 3 |
8.507000E-01 |
| Grade 2-vs-Grade 4 |
7.644400E-01 |
| Grade 3-vs-Grade 4 |
6.963200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.660800E-01 |
| Normal-vs-ccB subtype |
4.627500E-02 |
| ccA subtype-vs-ccB subtype |
2.659500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.944440E-01 |
| Normal-vs-N1 |
4.914000E-01 |
| N0-vs-N1 |
9.691200E-01 |
|
|
